Product NDC: | 50458-864 |
Proprietary Name: | NUCYNTA |
Non Proprietary Name: | tapentadol hydrochloride |
Active Ingredient(s): | 250 mg/1 & nbsp; tapentadol hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50458-864 |
Labeler Name: | Janssen Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA200533 |
Marketing Category: | NDA |
Start Marketing Date: | 20110825 |
Package NDC: | 50458-864-01 |
Package Description: | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-864-01) |
NDC Code | 50458-864-01 |
Proprietary Name | NUCYNTA |
Package Description | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-864-01) |
Product NDC | 50458-864 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | tapentadol hydrochloride |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20110825 |
Marketing Category Name | NDA |
Labeler Name | Janssen Pharmaceuticals, Inc. |
Substance Name | TAPENTADOL HYDROCHLORIDE |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Opioid Agonist [EPC],Opioid Agonists [MoA] |